MedPath

PICASSO: Prophylactic IncCsional Antibiotics in Skin Surgery trial. Can infiltrating antibiotics reduce the rate of wound infection?

Phase 4
Completed
Conditions
wound infection
graft failure
Surgery - Surgical techniques
Cancer - Non melanoma skin cancer
Cancer - Malignant melanoma
Registration Number
ACTRN12616000364471
Lead Sponsor
A/Prof (Hon) Jon Mathy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
2340
Inclusion Criteria

All patients waitlisted for surgical management of skin lesions following specialist evaluation at the CMDHB Skin Cancer Centre and whom are able to provide consent independently.

Exclusion Criteria

History of allergy to FLUCLOXACILLIN or CLINDAMYCIN.
Pre-operative administration of antibiotics.
Inability to return for follow up.
Inability to consent independently.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Wound infection: all surgical sites will be assessed at 5-10 days and 3-4 week time points postoperatively and graded for signs of infection as per the standardized scoring system adopted from Griego et al. <br>Griego R, Zitelli J. Intra-incisional prophylactic antibiotics for dermatologic surgery. Archives of Dermatology. 1998;134(6):688-92.[Once at 5 days post surgery and once at 3 weeks post surgery.]
Secondary Outcome Measures
NameTimeMethod
Graft take: all surgical sites closed with a skin graft will be assessed at 5-10 days and 3-4 week time points postoperatively and graded for percentage graft take. A transparent plastic film with a printed grid 1cm x 1cm will be used to estimate the total size of the graft and the percentage of graft take. Photographs will be taken for re-assessment by another observer.[Once at 5 days post surgery and once at 3 weeks post surgery.]
© Copyright 2025. All Rights Reserved by MedPath